Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes
1. In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...
Tag: sulfonylurea
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
